drugset / Trial / NCT04079140

Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion

NCT04079140

Phase 4 Completed 130 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate whether vaginal dinoprostone administered before the levonorgestrel-releasing intrauterine system(IUs) insertion reduces IUD insertion pain and difficulty in insertion in adolescents and young women.

Timeline

Start
2019-09-15
Primary completion
2019-11-30
Completion
2019-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 3 mg Other

Indications

No indication recorded.